Walsh Jeffrey T. 4
4 · bluebird bio, Inc. · Filed May 14, 2019
Insider Transaction Report
Form 4
Walsh Jeffrey T.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2019-05-10$24.47/sh+1,500$36,705→ 42,421 total - Sale
Common Stock
2019-05-10$131.10/sh−200$26,221→ 42,221 total - Sale
Common Stock
2019-05-10$132.38/sh−1,100$145,613→ 41,121 total - Sale
Common Stock
2019-05-10$133.08/sh−200$26,616→ 40,921 total - Exercise/Conversion
Stock Option (right to buy)
2019-05-10−1,500→ 11,521 totalExercise: $24.47Exp: 2024-03-03→ Common Stock (1,500 underlying)
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 2, 2018.
- [F2]The range of prices for the transaction reported on this line was $130.61 to $131.60. The average weighted price was $131.105. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The range of prices for the transaction reported on this line was $131.84 to $132.68. The average weighted price was $132.3755. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]The range of prices for the transaction reported on this line was $133.00 to $133.16. The average weighted price was $133.08. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]This option vested over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2015 and in 36 equal monthly installments thereafter.